articleTop 1% cited

Obesity as a risk factor for antipsychotic noncompliance

Schizophrenia Research · 2003 · Vol. 66(1) · pp. 51–57

Peter J. Weiden✉(SUNY Downstate Health Sciences University)Joan Mackell(Pfizer (United States))Diana D. McDonnell(Princeton University)

View via DOI Publisher page

Schizophrenia research and treatment Health Systems, Economic Evaluations, Quality of Life Bipolar Disorder and TreatmentAntipsychoticOverweightWeight gainMedicineObesityConfoundingBody mass indexPsychiatryDistressSchizophrenia (object-oriented programming)

MeSH terms

AdultAttitude to HealthBody ImageFemaleHealth SurveysHumansMaleObesityProfessional-Patient RelationsSchizophreniaSchizophrenic PsychologyAntipsychotic AgentsBody Mass IndexTreatment RefusalPatient Satisfaction

Funding

Pfizer

Citations

430

FWCI

12.07

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Integrating Physical Activity Into Mental Health Services for Persons With Serious Mental Illness

Psychiatric Services · 2005 · 493 citations

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

Molecular Psychiatry · 2007 · 708 citations

References

Cost of Relapse in Schizophrenia

Schizophrenia Bulletin · 1995 · 674 citations

Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis

American Journal of Psychiatry · 1999 · 2,384 citations

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

Psychological Medicine · 1983 · 1,023 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.